Learning Objective: After participating in this activity, learners should be better able to:
Evaluate the rationale for and current evidence supporting medication-assisted treatment of …

Completion of addiction treatment is one of the most consistent factors associated with a
favorable treatment outcome. Unfortunately, it is more common for a patient to drop-out of …

Background Buprenorphine maintenance treatment has been evaluated in randomised
controlled trials against placebo medication, and separately as an alternative to methadone …

Child Adolesc Psychiatric Clin N Am 25 (2016) 473–487 http://dx. doi. org/10.1016/j. chc.
2016.03. 002 childpsych. theclinics. com 1056-4993/16/$–see front matter© 2016 Elsevier …

Background: Medication adherence is critical to the effectiveness of psychopharmacologic
therapy. Psychiatric disorders present special adherence considerations, notably an altered …

Background Managed withdrawal is a necessary step prior to drug‐free treatment or as the
endpoint of substitution treatment. Objectives To assess the effects of buprenorphine versus …

Abstract Emerging adults (18–25 years old) are often poorly retained in substance use
disorder treatment. Office-based buprenorphine often enhances treatment retention among …

This paper is the thirty-fifth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2012 …

Introduction: This study explored factors influencing patient access to medications for opioid
use disorder (OUD), particularly for individuals eligible but historically suboptimal follow-up …

Background and Objectives Identifying predictors of early drop out from outpatient treatment
of opioid use disorder (OUD) with buprenorphine/naloxone (BN) may improve care for …